| 000 | 01782 a2200517 4500 | ||
|---|---|---|---|
| 005 | 20250516090504.0 | ||
| 264 | 0 | _c20120824 | |
| 008 | 201208s 0 0 eng d | ||
| 022 | _a1594-0667 | ||
| 024 | 7 |
_a10.1007/BF03325231 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aRavera, Enrico | |
| 245 | 0 | 0 |
_aControlled-release oxycodone tablets after transdermal-based opioid therapy in patients with cancer and non-cancer pain. _h[electronic resource] |
| 260 |
_bAging clinical and experimental research _c |
||
| 300 |
_a328-32 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article; Multicenter Study | ||
| 650 | 0 | 4 | _aAdministration, Cutaneous |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 |
_aAnalgesics, Opioid _xadministration & dosage |
| 650 | 0 | 4 |
_aBuprenorphine _xadministration & dosage |
| 650 | 0 | 4 | _aCross-Over Studies |
| 650 | 0 | 4 | _aDelayed-Action Preparations |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aFentanyl _xadministration & dosage |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aNeoplasms _xcomplications |
| 650 | 0 | 4 |
_aOxycodone _xadministration & dosage |
| 650 | 0 | 4 |
_aPain _xdrug therapy |
| 650 | 0 | 4 | _aPain Management |
| 650 | 0 | 4 |
_aPain Measurement _xdrug effects |
| 650 | 0 | 4 | _aPractice Guidelines as Topic |
| 650 | 0 | 4 | _aQuality of Life |
| 650 | 0 | 4 | _aTablets |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 | _aWorld Health Organization |
| 700 | 1 | _aDi Santo, Salvatore | |
| 700 | 1 | _aBosco, Rosa | |
| 700 | 1 | _aArboscello, Claudio | |
| 700 | 1 | _aChiarlone, Renato | |
| 773 | 0 |
_tAging clinical and experimental research _gvol. 23 _gno. 5-6 _gp. 328-32 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/BF03325231 _zAvailable from publisher's website |
| 999 |
_c21724462 _d21724462 |
||